Breath tests are important tools in clinical and research studies. Metabolic Solutions can measure the conversion of any 13C-substrate to 13CO2 or bacterial metabolism to hydrogen and methane (hydrogen breath tests).
Our advantages include:
- Customized test kits to meet your study needs
- CLIA and GLP compliance (including Part 11)
- Customized reporting of all data
- Validated stable isotope analysis
Several breath tests are available from Metabolic Solutions to quantitate liver function. These breath tests use a safe biologic substrate labeled with a non-radioactive isotope of carbon. Breath tests determine the rate of appearance of labeled carbon dioxide to estimate enzyme activity, organ function or presence of disease.
Metabolic Solutions can provide assistance with the following liver function breath tests:
Methionine Breath Test: Methionine is an essential amino acid that has important roles in various metabolic processes, including protein synthesis. The Methionine Breath Test uses 1-13C-methionine, which is a non-radioactive isotope and is metabolized exclusively by hepatic mitochondria. 13C-methionine metabolism within 20 minutes results in an increased concentration of 13CO2 in expired breath. The quantity of 13CO2 measured in breath correlates with liver disease severity. Our studies demonstrate the effectiveness of the Methionine Breath Test in measuring hepatic mitochondrial function in individuals with liver disease. See more information about the Methionine Breath Test.
Octanoate Breath Test: Impairment of mitochondrial beta-oxidation has been reported with several liver diseases such as nonalcoholic steatohepatitis (NASH). Sodium 1-13C-octanoate undergoes liver mitochondrial beta-oxidation. The sodium 1-13C-octanoate breath test was found to correlate with insulin resistance and predict the presence of NASH.
Phenylalanine Breath Test: Liver disease is associated with an abnormal elevation of the plasma concentrations of the aromatic amino acids, phenylalanine and tyrosine. The liver is the principal site of aromatic amino acid metabolism, particularly the hydroxylation of phenylalanine to tyrosine and further tyrosine degradation. We showed that the rate of hepatic phenylalanine metabolism can be quantitatively calculated from the appearance of 13CO2 in the breath using the non-radioactive tracer, L-[1-13C]phenylalanine. Many studies have demonstrated that the phenylalanine breath test quantitates hepatic cytosolic capacity in end-stage liver disease. See more information about the Phenylalanine Breath Test.
Cytochrome P450 Activity
Methacetin Breath Test: Methacetin is metabolized rapidly by hepatic microsomal enzymes. When 13C-methacetin is orally administered, it undergoes extensive liver first-pass clearance. Cytochrome P450 IA2 in liver cells converts methacetin via O-dealkylation to acetaminophen and 13CO2. The 13C-methacetin breath test (MBT) has been shown to accurately assess the degree of liver damage. The MBT can reliably distinguish between early cirrhotic and non-cirrhotic patients with 95% sensitivity and 97% specificity. The MBT can be completed within 60 minutes. Custom kits are available for clinical research studies. See more information about the Methacetin Breath Test.
Caffeine Breath Test: The [13C]caffeine breath test is highly specific for P4501A2 isoenzyme activity, which catalyzes caffeine 3-N-demethylation. Breath samples are collected over 1 h after oral administration, and the enzyme activity is quantified via analysis of the ratio of 13CO2 to 12CO2 by isotope ratio mass spectrometry. See more information about the Caffeine Breath Test.
Urea Breath Test: The urea breath (UBT) detects urease activity of Helicobacter pylori (H. pylori) in the stomach by administration of 13C-urea and monitoring 13CO2 in breath. Levels at a defined cutoff indicate the presence of the infection. The test may also be used to demonstrate that H. pylori has been eliminated by treatment with antibiotics.
Small Intestinal Bacterial Overgrowth: Small intestinal bacterial overgrowth (SIBO) is the overgrowth of bacteria in the small intestines. Normally sterile, the small intestines can be colonized with bacteria that reduce required nutrients from reaching the body and may cause small intestinal inflammation. SIBO is detected by administration of lactulose or glucose and monitoring their fermentation by bacteria to hydrogen and methane gas.
Lactose Breath Test: Lactose intolerance is the inability of the body to breakdown the milk sugar, lactose. This inability causes colonic gas, diarrhea, and abdominal pain. We use the hydrogen breath test for lactose intolerance that detects hydrogen and methane levels after administration of lactose.
Fructose Breath Test: The hallmark of fructose malabsorption is the lack of fructose absorption in the small intestines. Excess fructose reaching the colon can cause bloating, abdominal pain and diarrhea. Fructose malabsorption is detected by the hydrogen breath test after a 25 gram oral load of fructose.
Sucrose Breath Test: The sucrose breath test (SBT) assesses the health and function of the small intestine. Serious health ramifications can result if the functional area of the brush border is significantly reduced by damage caused by infection, surgical trauma, disease, antibiotics, use of certain drugs, and chemotherapy treatments. See more information about the Sucrose Breath Test.
Mixed Triglyceride Breath Test: The mixed triglyceride breath test is the most researched pancreatic function breath test. The breath test uses a triglyceride labeled with a medium chain fatty acid 13C-octanoate on the middle position of the glycerol backbone and two longer fatty acids (stearate) on positions 1 and 3. The principle of this breath test is to add the labeled triglyceride to a meal, where it is hydrolyzed to fatty acids by pancreatic lipases in the duodenum. The fatty acids are absorbed and transported to the liver for oxidation to 13CO2.
13C Lactose Ureide Breath Test: 13C-labeled glycosyl ureides can be used to measure oro-cecal transit time. Intestinal brush border enzymes are not able to split the glycosyl ureide bond between the sugar and urea. However, colonic bacteria are able to split this bond. By using 13C-urea, colonic bacteria oxidize this substrate to 13CO2. The initial rise in 13CO2 in the breath determines the oro-cecal transit time.
To discuss your research needs please contact us.